In a murine MM model, adiponectin deficiency was associated with bone disease and increased tumor load, whereas pharmacologic stimulation of adiponectin secretion prevented MM-induced bone lesions and resulted in prolongation of survival100. The gene discussed is ADIPOQ; the disease is Miyoshi myopathy.